HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

4-morpholinecarboximidine-N-1-adamantyl-N'-cyclohexylhydrochloride (U-37883A): pharmacological characterization of a novel antagonist of vascular ATP-sensitive K+ channel openers.

Abstract
This study describes the in vitro and in vivo characteristics of a guanidine 4-morpholinecarboximidine-N-1-adamantyl-N'-cyclohexyl-hydroc hloride (U-37883A), as an antagonist of vascular ATP-sensitive K+ channels (KATP). In isolated rabbit mesenteric artery, the antagonistic effects of U-37883A (0.5-5 microM) were studied against vasorelaxation produced by cromakalim (0.5 microM), minoxidil sulfate (5 microM), pinacidil (1 microM) and RP-49356 (1 microM). The dose-response curves for U-37883A against all four potassium channel openers were similar with U-37883A, IC50S ranging from 0.78 to 1.4 microM, suggesting that U-37883A is producing inhibition by acting at a step that is common to all four potassium channel openers during their activation of the vascular KATP. In contrast, U-37883A at 10 microM did not inhibit relaxation dose-response curves by nitroglycerine, forskolin or D600. U-37883A (1 or 10 microM) effectively inhibited as well as reversed 42K efflux-stimulated by cromakalim (1 microM) or minoxidil sulfate (5 microM). Finally, U-37883A (3 mg/kg i.v.) was found to inhibit significantly as well as reverse hypotension produced by minoxidil (1 mg/kg i.v. or 3 mg/kg p.o.), cromakalim (0.5 mg/kg p.o.) and pinacidil (0.3 mg/kg i.v.) in rats, cats and dogs. In contrast, the in vivo responses to phenylephrine, nitroglycerine, sodium nitroprusside or isoproterenol were not altered. U-37883A thus appears to be the first nonsulfonylurea shown to block consistently and selectively the in vitro as well as the in vivo pharmacological responses to various potassium channel openers. This structurally novel KATP antagonist therefore would be useful for further characterizing the mechanisms of pharmacological modulation of the KATP in a variety of cell systems.
AuthorsK D Meisheri, S J Humphrey, S A Khan, L A Cipkus-Dubray, M P Smith, A W Jones
JournalThe Journal of pharmacology and experimental therapeutics (J Pharmacol Exp Ther) Vol. 266 Issue 2 Pg. 655-65 (Aug 1993) ISSN: 0022-3565 [Print] United States
PMID8355199 (Publication Type: Journal Article)
Chemical References
  • Benzopyrans
  • Morpholines
  • Potassium Channels
  • Pyrroles
  • Cromakalim
  • minoxidil sulfate ester
  • U 37883A
  • Minoxidil
  • Adenosine Triphosphate
  • Adamantane
  • Potassium
Topics
  • Adamantane (analogs & derivatives, pharmacology)
  • Adenosine Triphosphate (pharmacology)
  • Animals
  • Benzopyrans (pharmacology)
  • Blood Pressure (drug effects)
  • Cats
  • Cromakalim
  • Dogs
  • Female
  • In Vitro Techniques
  • Male
  • Mesenteric Arteries (drug effects, physiology)
  • Minoxidil (analogs & derivatives, pharmacology)
  • Morpholines (pharmacology)
  • Potassium (metabolism)
  • Potassium Channels (drug effects)
  • Pyrroles (pharmacology)
  • Rabbits
  • Rats
  • Rats, Sprague-Dawley
  • Vasodilation (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: